** Shares of healthcare products distributor Henry Schein HSIC.O rise 6.2% to $73.09
** Activist investor Ananym Capital Management is urging Henry Schein to refresh its board, cut costs, tackle succession planning and consider selling its medical distribution business
** Ananym argues that Schein needs new board members and ultimately a new CEO to tackle spending, according to a Reuters report
** Ananym says medical distribution business sale could increase stock price by 20%
** Including session's move, stock down 2.1% YTD
(Reporting by Christy Santhosh)
((Christy.Santhosh@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。